18.01.2017 • News

Givaudan Acquires Activ International

(c) Lichtmeister/Shutterstock
(c) Lichtmeister/Shutterstock

As part of an ongoing strategy to expand its product portfolio and invest in high-growth markets, Swiss flavors and fragrances company Givaudan has added local firm Activ International to the group. Financial terms of the transaction were not disclosed.

With headquarters in Bienne, Switzerland, and sites in Paris, France; Somerset, New Jersey, USA; Melaka, Malaysia; and Arequipa, Peru, Activ employs 170 people around the world to provide a range of natural and organic flavor products.

Mauricio Graber, president of Givaudan’s Flavor Division said Activ’s portfolio further enables the Swiss group to strengthen its extensive natural flavor offerings and supply customers with complete and competitive natural solutions.

Activ’s business would have accounted for incremental sales amounting to approximately 40 million Swiss francs in Givaudan’s 2016 results on a proforma basis. Givaudan posted sales of 4.4 billion Swiss francs in 2015.

The Vernier-headquartered company said it will fund the acquisition from existing resources. Last July, Givaudan paid $340 million to buy US-based Spicetec Flavors & Seasonings from ConAgra Foods.

Interview

Driving Sustainability Through Collaboration
Building Green Practices Across the Chemical Supply Chain

Driving Sustainability Through Collaboration

Together for Sustainability (TfS) is a pioneering, member-led initiative working to accelerate sustainable and resilient chemical supply chains. TfS President Jennifer Jewson discusses the origins of TfS, its evolving goals, its present-day challenges, and the initiative’s enduring impact and outlook for the future.

Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

most read